synagis 100 mg injection
abbvie (pty) ltd - injection - each 1,0 ml solution contains palivizumab 100,0 mg
synagis injection
astrazeneca pharmaceuticals (pty) ltd - injection - see ingredients - each 1,0 ml solution contains palivizumab 100,0 mg
synagis® 100 mg/ml (50 mg/0.5 ml) injection
city medical store - sole proprietorship l.l.c italy - 1 glass vial - injection - 50 mg/0.5 ml - infections-antiviral
synagis® 100 mg/ml (100 mg/1 ml) injection
city medical store - sole proprietorship l.l.c italy - 1 glass vial - injection - 100 mg/1 ml - infections-antiviral
synagis® 100 mg/ml (100 mg/1 ml)
1 glass vial -
synagis® 100 mg/ml (50 mg/0.5 ml)
1 glass vial -
synagis 50mg/0.5ml solution for injection 50 mg/0.5 ml
مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - palivizumab 50 mg/0.5 ml - 50 mg/0.5 ml
synagis 100mg\ml i.m solution for injection
astrazeneca ab, sweden - palivizumab - solution for injection - 100 mg/ml
synagis 100mg\ml i.m vial solution
abbott laboratories - palivizumab - solution - 100 mg/ml
synagis 50
abbvie (pty) ltd - palivizumab - injection - each 0.5ml vial when reconstituted contains palivizumab 50,0 mg